ArticleLife (Basel, Switzerland)2020

The Impact of a New Interleukin-2-Based Immunotherapy Candidate on Urothelial Cells to Support Use for Intravesical Drug Delivery.

Lisa Schmitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.